Salidroside attenuates LPS-stimulated activation of THP-1 cell-derived macrophages through down-regulation of MAPK/NF-kB signaling pathways

Abstract

Excessive activation of macrophages is implicated in various inflammatory injuries. Salidroside (Sal), one of the main bioactive components of Rhodiola Sachalinensis, has been reported to possess anti-inflammatory activities. This study aimed to examine the effect of Sal on the activation of macrophages and the possible mechanism. The lipopolysaccharide (LPS)-stimulated phrobol 12-myristate 13-acetate (PMA)-differentiated THP-1 macrophage models were established. The changes in the inflammatory profiles of THP-1-derived macrophages were determined. The results showed that Sal significantly decreased the expression of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX2), interleukin-1beta (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) at both mRNA and protein levels in THP-1-derived macrophages, and the effect was dose-depedent. Moreover, NF-κB activation was significantly suppressed and the phosphorylation of ERK, p38 and JNK was substantially down-regulated after Sal treatment. The findings suggested that Sal can suppress the activation of LPS-stimulated PMA-differetiated THP-1 cells, as evidenced by the decreased expression of iNOS, COX2, IL-1β, IL-6 and TNF-α, and the mechanism involves the inhibition of NF-κB activation and the phosphorylation of the MAPK signal pathway.

Keywords

salidroside / THP-1 / MAPK / LPS / NF-κB

References

[1] TabasI, GlassCK. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science, 2013, 339(6116): 166-172

[2] LewisDH, ChanDL, PinheiroD, et al.. The immunopathology of sepsis: pathogen recognition, systemic inflammation, the compensatory anti-inflammatory response, and regulatory T cells. J Vet Intern Med, 2012, 26(3): 457-482

[3] ChoyE. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford), 2012, 51(Suppl5): v3-v11

[4] VucevićD, RadakD, RadosavljevićT, et al.. Inflammatory process in atherogenesis: new facts about old flame. Arterioscler Thromb Vasc Biol, 2012, 65(9-10): 388-395

[5] HurstingSD, HurstingMJ. Growth signals, inflammation, and vascular perturbations: mechanistic links between obesity, metabolic syndrome, and cancer. Arterioscler Thromb Vasc Biol, 2012, 32(8): 1766-1770

[6] OlsonN, van der VlietA. Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease. Nitric Oxide, 2011, 25(2): 125-137

[7] SautebinL. Prostaglandins and nitric oxide as molecular targets for anti-inflammatory therapy. Fitoterapia, 2000, 71(Suppl1): S48-S57

[8] SharmaJN, Al-OmranA, ParvathySS. Role of nitric oxide in inflammatory diseases. Inflammopharmacology, 2007, 15(6): 252-259

[9] MartinezFO, HelmingL, GordonS. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol, 2009, 27: 451-483

[10] AderemA. Role of Toll-like receptors in inflammatory response in macrophages. Crit Care Med, 2001, 29(7Suppl): S16-S18

[11] DobrovolskaiaMA, VogelSN. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect, 2002, 4(9): 903-914

[12] GuhaM, MackmanN. LPS induction of gene expression in human monocytes. Cell Signal, 2001, 13(2): 85-94

[13] SchmidD, GruberM, PiskatyC, et al.. Inhibition of NF-κB-dependent cytokine and inducible nitric oxide synthesis by the macrocyclic ellagitannin oenothein B in TLR-stimulated RAW 264.77 macrophages. J Nat Prod, 2012, 75(5): 870-875

[14] ChenF, HeSS, QiuRY, et al.. Influence of Silencing TRAF6 with shRNA on LPS/TLR4 Signaling in vitro. J Huazhong Univ Sci Technol [Med Sci], 2010, 30(3): 278-284

[15] GuoN, HuZ, FanX, et al.. Simultaneous determination of salidroside and its aglycone metabolite p-tyrosol in rat plasma by liquid chromatography-tandem mass spectrometry. Molecules, 2012, 17(4): 4733-4754

[16] GuanS, FengH, SongB, et al.. Salidroside attenuates LPS-induced pro-inflammatory cytokine responses and improves survival in murine endotoxemia. Int Immunopharmacol, 2011, 11(12): 2194-2199

[17] LiD, FuY, ZhangW, et al.. Salidroside attenuates inflammatory responses by suppressing nuclear factor-κB and mitogen activated protein kinases activation in lipopolysaccharide-induced mastitis in mice. Inflamm Res, 2013, 62(1): 9-15

[18] GuanS, XiongY, SongB, et al.. Protective effects of salidroside from Rhodiola rosea on LPS-induced acute lung injury in mice. Immunopharmacol Immunotoxicol, 2012, 34(4): 667-672

[19] KucinskaiteA, BriedisV, SavickasA. Experimental analysis of therapeutic properties of Rhodiola rosea L. and its possible application in medicine. Medicina (Kaunas), 2004, 40: 614-619

[20] MaoGX, WangY, QiuQ, et al.. Salidroside protects human fibroblast cells from premature senescence induced by H(2)O(2) partly through modulating oxidative status. Mech Ageing Dev, 2010, 131(11-12): 723-731

[21] WuYL, LianLH, JiangYZ, et al.. Hepatoprotective effects of salidroside on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice. J Pharm Pharmacol, 2009, 61(10): 1375-1382

[22] LiF, TangH, XiaoF, et al.. Protective effect of salidroside from Rhodiolae Radix on diabetes-induced oxidative stress in mice. Molecules, 2011, 16(12): 9912-9924

[23] DaigneaultM, PrestonJA, MarriottHM, et al.. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One, 2010, 5(1): e8668

[24] HeX, ShuJ, XuL, et al.. Inhibitory effect of Astragalus polysaccharides on lipopolysaccharide-induced TNF-α and IL-1β production in THP-1 cells. Molecules, 2012, 17(3): 3155-3164

[25] DilsharaMG, JayasooriyaRG, LeeS, et al.. Water extract of processed Hydrangea macrophylla (Thunb.) Ser. leaf attenuates the expression of pro-inflammatory mediators by suppressing Akt-mediated NF-κB activation. Environ Toxicol Pharmacol, 2013, 35(2): 311-319

[26] ConnellyL, Palacios-CallenderM, AmeixaC, et al.. Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide. J Immunol, 2001, 166(6): 3873-3781

[27] CuccurulloC, FaziaML, MezzettiA, et al.. COX-2 expression in atherosclerosis: the good, the bad or the ugly?. Curr Med Chem, 2007, 14(15): 1595-1605

[28] LocksleyRM, KilleenN, LenardoMJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell, 2001, 104(4): 487-501

[29] WanF, LenardoMJ. The nuclear signaling of NF-kappaB: current knowledge, new insights, and future perspectives. Cell Res, 2010, 20(1): 24-33

[30] López-FrancoO, SuzukiY, SanjuánG, BlancoJ, et al.. Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis. Am J Pathol, 2002, 161(4): 1497-1505

[31] WangS, LiuZ, WangL, et al.. NF-kappaB signaling pathway, inflammation and colorectal cancer. Cell Mol Immunol, 2009, 6(5): 327-334

[32] CorbettaS, VicentiniL, FerreroS, et al.. Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors. Endocr Relat Cancer, 2005, 12(4): 929-937

[33] LeeAK, SungSH, KimYC, et al.. Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-alpha and COX-2 expression by sauchinone effects on I-kappaB alpha phosphorylation, C/EBP and AP-1 activation. Br J Pharmacol, 2003, 139(1): 11-20

[34] Marks-KonczalikJ, ChuSC, MossJ. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites. J Biol Chem, 1998, 273(35): 22201-22208

[35] JohnsonGL, LapadatR. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science, 2002, 298(5600): 1911-1912

[36] DaiJN, ZongY, ZhongLM, et al.. Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways. PLoS One, 2011, 6(7): e21891

[37] LeeMS, KwonMS, ChoiJW, et al.. Anti-inflammatory activities of an ethanol extract of Ecklonia stolonifera in lipopolysaccharide-stimulated RAW 264.7 murine macrophage cells. J Agric Food Chem, 2012, 60(36): 9120-9129

[38] ChengYW, ChangCY, LinKL, et al.. Shikonin derivatives inhibited LPS-induced NOS in RAW 264.7 cells via downregulation of MAPK/NF-kappaB signaling. J Ethnopharmacol, 2008, 120(2): 264-271

[39] XieC, KangJ, FergusonME, et al.. Blueberries reduce pro-inflammatory cytokine TNF-alpha and IL-6 production in mouse macrophages by inhibiting NF-kappaB activation and the MAPK pathway. Mol Nutr Food Res, 2011, 55(10): 1587-1591

[40] ChuX, CiX, HeJ, et al.. A novel anti-inflammatory role for ginkgolide B in asthma via inhibition of the ERK/MAPK signaling pathway. Molecules, 2011, 16(9): 7634-7648

[41] HuangH, FletcherA, NiuY, et al.. Characterization of lipopolysaccharide-stimulated cytokine expression in macrophages and monocytes. Inflamm Res, 2012, 61(12): 1329-1338

[42] FitzgeraldML, MooreKJ, FreemanMW, et al.. Lipopolysaccharide induces scavenger receptor A expression in mouse macrophages: a divergent response relative to human THP-1 monocyte/macrophages. J Immunol, 2000, 164(5): 2692-2700

[43] LeeCS, ShinYJ, WonC, et al.. Simvastatin acts as an inhibitor of interferon gamma-induced cycloxygenase-2 expression in human THP-1 cells, but not in murine RAW264.7 cells. Biocell, 2009, 33(2): 107-114